Skip to content

Bristol-Myers Squibb

US · BMY #158 by market cap Listed 1970
58.80 +0.46 +0.79%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Bristol-Myers Squibb

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Founded
1933
CEO
Dr. Christopher S. Boerner, PhD
Employees
32,500
Headquarters
Princeton, New Jersey, United States of America
Fiscal year end
12-31
Website
bms.com

Company profile

Exchange
US
Symbol
BMY
Market-cap rank
#158
Listing date
1970-01-01
Market cap
120.19B
Float cap
120.00B
Shares out
2.04B
Float shares
2.04B

Sectors & themes

Drug Manufacturers - General Cancer Research Government Pension Fund of Norway Global medical industry Regular Savings Plan Fractional Shares JP Star Stocks

Browse all sectors & themes

Quote time 2026-11-20 20:02:42 · For reference only, not investment advice and not tailored to your situation.

Bristol-Myers Squibb discussion 0 comments

Add a comment